Drug intelligence / Profile preview

SUPPLEMEANT to Be

Development stage: Unknown
Lead developer: DERMALA
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

SUPPLEMEANT to Be is an oral dietary supplement developed by DERMALA for the management of acne. It is formulated as a daily pre- and probiotic supplement designed to target the gut-skin axis by balancing the gut microbiome. The product contains a proprietary prebiotic mix (PreforPro bacteriophages), a multi-strain probiotic blend (including Bacillus subtilis DE111, Bifidobacterium longum, Bifidobacterium lactis Bi-07, Lactobacillus plantarum, Bifidobacterium lactis, and Lactobacillus rhamnosus), and a combination of vitamins (A, C, E) and zinc. Its mechanism of action involves promoting a healthy intestinal microbiota to reduce systemic inflammation and skin oiliness, thereby supporting clearer skin. It is marketed as part of the #FOBO (Fear of Breaking Out) acne treatment system and is classified as a nutraceutical rather than a pharmaceutical drug.

Brand names: SUPPLEMEANT to Be
Other names: SUPPLEMEANT to Be Pre + Probiotic + Vitamin Acne Supplement

Beyond the preview

Go deeper on SUPPLEMEANT to Be.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUPPLEMEANT to Be.

Explore the full profile